Search

everythinglearnresearchcommunity

for

Search:↓

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Minoxidil can help regrow hair in alopecia areata patients.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Careful management of blood thinners is crucial for lupus patients with APS.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

A family showed a new condition with inherited hair loss and skin changes, possibly due to one genetic disorder.